Literature DB >> 23807452

[Proctocolectomy in ulcerative colitis : is a multistep procedure in cases of immunosuppression advisable?].

C Seifarth1, J Gröne, N Slavova, B Siegmund, H J Buhr, J-P Ritz.   

Abstract

BACKGROUND: The coloproctomucosectomy (CPM) is the procedure of the choice for the surgical treatment of ulcerative colitis (UC). In cases with pronounced immunosuppression (IS), a 3-step (3S) procedure [i.e., subtotal colectomy and ileal pouch-anal anastomosis (IPAA) and finally ileostomy reconstruction] is often selected. Fewer perioperative complications can be expected compared to the 2-step (2S) procedure; however, an additional in-hospital stay and surgical intervention are necessary. The aim of the present study was to compare both approaches using the clinical outcome of our patients undergoing IPAA to determine efficacy of these two concepts. PATIENTS AND METHODS: From 1997-2010, a total of 225 patients were operated using a 2S or 3S IPAA procedure. Clinical outcomes were evaluated based on the number of surgical steps for the ileoanal pouch procedure and IPAA. The survey was performed within the scope of prospective study.
RESULTS: Of the 225 patients with CPM, 66 were excluded due to a diagnosis other than UC (familial adenomatous polyposis, indeterminate colitis, Crohn's disease) and patients with permanent ILS procedures without the possibility or wish for an IPAA (n =  54). Included were 71 patients with 2S (w = 30, m = 41) and 34 patients with 3S procedures (w = 21, m = 13). Compared to the 2S procedure, the 3S procedure was shown to have shorter operation times (246 versus 296 min; p  = 0.05), shorter hospital stays (15.5 versus 24.6 days; p = 0.05), shorter intensive care unit stays (3.3 versus 7.2 days; p = 0.05), and fewer major complications (5.9 % versus 22.5 %; p = 0.035). Patients with 3S procedures had a higher BMI (26.2 versus 23.1 kg/m²; p = 0.05) and fewer required IS (10 % vs. 62 %; p < 0.05).
CONCLUSION: The decision for a 3S procedure in UC and pronounced IS is advisable and justified. Using a 3S procedure, immunosuppression and its influence on perioperative morbidity are thus reduced. The IPAA can be performed with shorter operation times, shorter hospital stays and fewer major complications.

Entities:  

Mesh:

Year:  2013        PMID: 23807452     DOI: 10.1007/s00104-013-2552-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  29 in total

1.  Timing and indications for colectomy in chronic ulcerative colitis: Surgical consideration.

Authors:  Robert R Cima
Journal:  Dig Dis       Date:  2010-09-30       Impact factor: 2.404

2.  Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols.

Authors:  Ute Günther; Dajana Kusch; Frank Heller; Nataly Bürgel; Silke Leonhardt; Severin Daum; Britta Siegmund; Christoph Loddenkemper; Maria Grünbaum; Heinz-Johannes Buhr; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

3.  Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?

Authors:  Oded Zmora; Marat Khaikin; Turab Pishori; Alon Pikarsky; Adam Dinnewitzer; Eric G Weiss; Juan J Nogueras; Steven D Wexner
Journal:  Int J Colorectal Dis       Date:  2006-08-24       Impact factor: 2.571

4.  Surgery for ulcerative colitis in 1,000 patients.

Authors:  Hiroki Ikeuchi; Motoi Uchino; Hiroki Matsuoka; Toshihiro Bando; Takayuki Matsumoto; Naohiro Tomita; Yasutugu Syoji; Masato Kusunoki; Takehira Yamamura; Joji Utsunomiya
Journal:  Int J Colorectal Dis       Date:  2010-03-09       Impact factor: 2.571

5.  Outcomes after laparoscopic surgery in children with inflammatory bowel disease.

Authors:  Ivan R Diamond; J Ted Gerstle; Peter C W Kim; Jacob C Langer
Journal:  Surg Endosc       Date:  2010-04-16       Impact factor: 4.584

6.  Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.

Authors:  Alaa El-Hussuna; Jens Andersen; Thue Bisgaard; Per Jess; Mads Henriksen; Jacob Oehlenschlager; Ole Thorlacius-Ussing; Gunnar Olaison
Journal:  Scand J Gastroenterol       Date:  2012-04-10       Impact factor: 2.423

7.  Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients.

Authors:  Adrian A Indar; Tonia M Young-Fadok; Jacques Heppell; Jonathan E Efron
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

8.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

9.  Laparoscopic total proctocolectomy with ileal pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis: initial experience in Mexico.

Authors:  F López-Rosales; Q González-Contreras; L J Muro; M M Berber; H T Cid de León; O V Fernández; R R Veana
Journal:  Surg Endosc       Date:  2007-08-20       Impact factor: 4.584

10.  Laparoscopic restorative proctocolectomy with and without previous subtotal colectomy.

Authors:  I McAllister; P M Sagar; I Brayshaw; S Gonsalves; G L Williams
Journal:  Colorectal Dis       Date:  2008-05-29       Impact factor: 3.788

View more
  3 in total

Review 1.  [Refractory inflammatory bowel disease: surgical challenges].

Authors:  H J Buhr; A J Kroesen
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

2.  Inflammation of the rectal remnant endangers the outcome of ileal pouch-anal anastomosis: a case-control study.

Authors:  Jan P Frese; Jörn Gröne; Johannes C Lauscher; Martin E Kreis; Benjamin Weixler; Katharina Beyer; Claudia Seifarth
Journal:  Int J Colorectal Dis       Date:  2022-06-17       Impact factor: 2.796

3.  Impact of staged surgery on quality of life in refractory ulcerative colitis.

Authors:  Claudia Seifarth; Lara Börner; Britta Siegmund; Heinz Johannes Buhr; Jörg-Peter Ritz; Jörn Gröne
Journal:  Surg Endosc       Date:  2016-06-17       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.